Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Links shared publicly online about this topic.
- 1,741total visits
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
View full resource at drugs.com
Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, FDA, Diovan, Novartis
Most Recently Shared on September 18, 2009 at 6:26 pm By:
Novartis receives FDA approval for Valturna, a single-pill ... http://bit.ly/3Ev3SQ
Also Shared By:
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
novartis.com — “Basel, September 17, 2009 - The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure[2]. This is the first approval for Valturna, which is indicated for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (AR” View full resource at novartis.com
Most Recently Shared on September 18, 2009 at 7:52 am By:
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren http://twurl.nl/samel4
Advertisement
Drugs.com
@Drugscom
FDA Approves Valturna (aliskiren and valsartan) to treat high blood pressure - http://bit.ly/2jfQfe
1 year ago...